Mellon Medical

What Mellon Medical does

Mellon Medical is a Netherlands-based medical device company founded in 2013 by Dutch vascular surgeon Mark Vrancken Peeters to develop precision surgical suturing tools. Its core product is the Switch®, a single-patient-use suturing device that enables true one-handed suturing through a pinch-activated automatic needle transfer between two jaws along a predictable linear path. The device is designed specifically to enable the small-bites suturing technique in abdominal wall closure, which has been clinically validated by research at Erasmus MC to reduce incisional hernia incidence by approximately 50%. The product platform consists of the Switch® device, a Switch-Aid® needle loader included with every suture set, and dedicated polydioxanone (PDS) suture sets manufactured in partnership with Assut Europe.

The company operates a B2B medical device go-to-market targeting hospitals and surgical centers, planned as a direct enterprise sales model once CE mark and FDA approval are obtained. The Switch is positioned as the first device capable of performing abdominal wall closure using the small-bites technique in general surgery, with documented claims of twice the suturing speed of conventional techniques. Mellon Medical is pre-commercial, still in development and clinical validation, and is currently active in medical congresses (EHS-AHS, Hernia Prevention Congress, Charing Cross) and KOL engagement to build clinical credibility. The company has secured approximately €10 million in equity financing across rounds in 2017 and 2020, supplemented by a Eurostars grant in 2022, and became a fully integrated subsidiary of the Demcon Group in April 2024 to access scalable manufacturing and engineering capabilities ahead of market introduction.

Name

Mellon Medical

Legal name

Mellon Medical

Website

https://mellonmedical.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

1–10 employees

Short description

Mellon Medical is a Netherlands-based medical device company developing the Switch®, a single-patient-use surgical suturing device that enables one-handed suturing and the small-bites technique for abdominal wall closure, targeting hospitals and surgeons to reduce incisional hernia rates. The company is pre-commercial and operates as a subsidiary of Demcon Group.

Ownership category

akta.pro rank

Product category

Surgical Suturing Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)

Keywords

• Surgical suturing devices
• Abdominal wall closure
• Single-handed suturing
• Medical device manufacturing
• Suture consumables

Headquarters

HQ city

Enschede

HQ country

Netherlands

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations

Revenue model

1. Single-Patient Use Surgical Device: The Switch is sold as a single-patient use disposable suturing device with dedicated suture sets. Each unit is used once and discarded, creating a recurring revenue stream tied to surgical procedure volume.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels3 records

Core offering

Mellon Medical develops and manufactures the Switch®, a single-patient-use precision surgical suturing device that enables true one-handed suturing for abdominal wall closure via a pinch-activated automatic needle transfer between dual jaws. The Switch® is sold as an integrated system with the Switch-Aid® needle loader and dedicated polydioxanone (PDS) suture sets, targeting hospitals, surgical centers, and general surgeons performing laparotomies and high-demand general surgery procedures.

Product overview

Mellon Medical offers the Switch® platform technology consisting of a precision surgical suturing device, a dedicated needle loader accessory, and compatible suture sets. The core Switch® device enables one-handed suturing through an innovative jaw-based needle transfer mechanism, specifically optimized for the small-bites technique in abdominal wall closure. The Switch-Aid® needle loader is included with every suture set to facilitate safe loading of the device. All components work together as an integrated single-patient-use suturing system for general surgery applications.

Differentiator

Problem solved

Functional benefit

Brands

• Switch®: The Switch® is a precision surgical suturing device for abdominal wall closure, enabling one-handed suturing and the small-bites technique to reduce incisional hernias.

Products and services

• Switch® Suturing Device A single-patient-use precision surgical suturing device that enables true one-handed suturing through a pinch-activated automatic needle transfer between two jaws. Designed for general surgeons performing abdominal wall closure using the small-bites technique, it features a straight double-pointed needle on a predictable linear path, a small-bite ruler enforcing 5–7mm stitch pitch, and a pencil-form ergonomic design suitable for both right- and left-handed surgeons.
• Switch® Suture Set A custom polydioxanone (PDS) suture set designed for use with the Switch® device, featuring atraumatic single-armed needle-suture combinations. Each set includes a Switch-Aid® needle loader and supports multiple needle and suture combinations for different surgical needs. PDS is widely valued for its strength, predictable absorption, and minimal tissue reaction.

Quantifiable outcome

• Sutures placed twice as fast as conventional technique
• +3 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Four partnerships are on record, tiered core.

• Demcon GroupcoreStrategic or Co-development Partner · 1 April 2024Since April 2024, Mellon Medical has become part of the Demcon Group. Demcon is a Dutch high-tech engineering company that develops advanced systems across medical, industrial and scientific domains. Within the group, Mellon benefits from Demcon Life Sciences & Health team expertise in high-end engineering and scalable manufacturing.
• Assut Europe SPAcoreStrategic or Co-development Partner · 30 November 2022Italian manufacturer of surgical sutures joined as partner to develop and produce the custom needle-thread combination (suture set) for the Switch device. Part of the research consortium with Erasmus MC and Demcon for Eurostars grant.
• Erasmus Medical Center RotterdamcoreStrategic or Co-development Partner · 1 January 2013Renowned academic hospital providing clinical validation of the Switch device. Research by Erasmus MC established small-bites suturing as superior standard for abdominal wall closure. Top surgeons from Netherlands, Europe, and US on advisory board guiding development. Mellon has official research agreement with Erasmus MC.
• Demcon Innovation & TechnologycoreStrategic or Co-development PartnerDemcon innovation & technology contributed to €4 million development funding in 2020. Supporting further development and production of the suturing instrument.

Scale indicators10 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Smith+Nephew: Smith+Nephew's Advanced Wound Management and Sports Medicine franchises include wound closure and surgical device portfolios. As a broad incumbent with global surgical salesforce reach, it overlaps with Switch in general surgery wound closure and would be a comparable strategic acquirer profile.
• Medtronic: Medtronic's Surgical Innovations business (including the former Covidien portfolio) offers sutures, staplers, and advanced energy devices for general and vascular surgery. As a broad incumbent with strong surgeon relationships and US salesforce scale, it represents a competitive threat and a relevant exit/strategic partner benchmark.
• Ethicon (Johnson & Johnson): Ethicon is the dominant global sutures and surgical stapling franchise within Johnson & Johnson, offering comprehensive suturing, hemostasis, and closure portfolios. It is the primary incumbent Mellon must displace in hospital procurement and represents the most direct competitive benchmark for Switch's go-to-market.

Direct peers

• B. Braun Surgical: B. Braun Surgical manufactures sutures, surgical instruments, and wound closure devices for global hospital markets, with strong European presence mirroring Mellon's home geography. It is a direct competitor in the sutures and suturing device category and a logical strategic acquirer or distribution partner.
• CONMED Corporation:
• Teleflex: Teleflex offers surgical instruments and specialty suturing devices across general, cardiovascular, and orthopedic surgery, with established US hospital sales infrastructure. It is directly comparable to Mellon in surgical instrumentation and represents a plausible strategic acquirer given its history of bolt-on medtech M&A.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/mellonmedical
• LinkedInlinkedin.com/company/mellon-medical-b-v-

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds2 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mellon Medical